7.18
price up icon2.57%   0.18
after-market 시간 외 거래: 7.30 0.12 +1.67%
loading
전일 마감가:
$7.00
열려 있는:
$6.99
하루 거래량:
641.26K
Relative Volume:
2.47
시가총액:
$156.96M
수익:
$52.55M
순이익/손실:
$-23.69M
주가수익비율:
-7.6383
EPS:
-0.94
순현금흐름:
$-15.29M
1주 성능:
+2.57%
1개월 성능:
-7.12%
6개월 성능:
+79.95%
1년 성능:
+250.24%
1일 변동 폭
Value
$6.7525
$7.305
1주일 범위
Value
$6.6472
$7.305
52주 변동 폭
Value
$1.78
$7.95

Exagen Inc Stock (XGN) Company Profile

Name
명칭
Exagen Inc
Name
전화
(760) 560-1501
Name
주소
1261 LIBERTY WAY, VISTA, CA
Name
직원
209
Name
트위터
@ExagenInc
Name
다음 수익 날짜
2025-03-11
Name
최신 SEC 제출 서류
Name
XGN's Discussions on Twitter

XGN을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Diagnostics & Research icon
XGN
Exagen Inc
7.18 153.02M 52.55M -23.69M -15.29M -0.94
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
424.98 162.60B 42.90B 6.52B 6.72B 17.05
Diagnostics & Research icon
DHR
Danaher Corp
194.79 147.08B 23.82B 3.77B 4.90B 5.15
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
518.71 43.52B 3.93B 894.97M 837.70M 10.82
Diagnostics & Research icon
A
Agilent Technologies Inc
116.36 35.27B 6.63B 1.17B 1.19B 4.05
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
163.25 28.64B 15.50B 1.33B 2.16B 7.34

Exagen Inc Stock (XGN) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2022-08-05 다운그레이드 KeyBanc Capital Markets Overweight → Sector Weight
2021-10-15 재개 Cowen Outperform
2021-04-15 개시 Canaccord Genuity Buy
2020-11-10 개시 KeyBanc Capital Markets Overweight
2020-10-08 개시 BTIG Research Buy
2020-06-02 재개 Cantor Fitzgerald Overweight
2019-10-14 개시 Cantor Fitzgerald Overweight
2019-10-14 개시 Cowen Outperform
2019-10-14 개시 William Blair Outperform
모두보기

Exagen Inc 주식(XGN)의 최신 뉴스

pulisher
Jul 17, 2025

Exagen Appoints Chas McKhann to Board of Directors - TipRanks

Jul 17, 2025
pulisher
Jul 17, 2025

Exagen Inc. Appoints Chas McKhann to Board of Directors - AInvest

Jul 17, 2025
pulisher
Jul 17, 2025

Exagen appoints Chas McKhann to board of directors - Investing.com Australia

Jul 17, 2025
pulisher
Jul 17, 2025

Exagen Strengthens Board with Healthcare Veteran Behind Two Boston Scientific Acquisitions - Stock Titan

Jul 17, 2025
pulisher
Jul 16, 2025

Michael Mahler Joins Exagen as Chief Scientific Officer - Medical Product Outsourcing

Jul 16, 2025
pulisher
Jul 16, 2025

Exagen Inc. to Announce Second Quarter 2025 Financial Results on July 29, 2025 - GlobeNewswire

Jul 16, 2025
pulisher
Jul 15, 2025

What makes Exagen Inc. stock price move sharplyFree Expert Investment Advice - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How Exagen Inc. stock performs during market volatilityFree Risk Assessment Services - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Exagen Inc. Announces Second Quarter 2025 Financial Results Release Date - AInvest

Jul 15, 2025
pulisher
Jul 15, 2025

Exagen Inc. to Announce Q2 2025 Financial Results and Host Conference Call on July 29 - Quiver Quantitative

Jul 15, 2025
pulisher
Jul 15, 2025

Exagen Schedules Q2 2025 Earnings: CEO and CFO to Present Before Market Opens July 29 - Stock Titan

Jul 15, 2025
pulisher
Jul 15, 2025

Why Exagen Inc. stock attracts strong analyst attentionTrending Stock Alert - Newser

Jul 15, 2025
pulisher
Jun 30, 2025

Exagen Inc.(NasdaqGM: XGN) added to Russell 3000E Index - MarketScreener

Jun 30, 2025
pulisher
Jun 30, 2025

Exagen Inc.(NasdaqGM: XGN) added to Russell Microcap Growth Index - MarketScreener

Jun 30, 2025
pulisher
Jun 29, 2025

Exagen Insider Ups Holding During Year - Yahoo

Jun 29, 2025
pulisher
Jun 29, 2025

Exagen Inc. (XGN): Insider Confidence and Undervaluation Signal Buying Opportunity Ahead of Key Earnings - AInvest

Jun 29, 2025
pulisher
Jun 24, 2025

Exagen announces resale of up to 1.15M shares - MSN

Jun 24, 2025
pulisher
Jun 23, 2025

Exagen appoints Michael Mahler as CSO - TipRanks

Jun 23, 2025
pulisher
Jun 23, 2025

Leading Autoimmune Researcher Dr. Mahler Joins Exagen: 300+ Publications and Game-Changing Diagnostic Patents - Stock Titan

Jun 23, 2025
pulisher
Jun 14, 2025

Analysts Issue Forecasts for Exagen FY2026 Earnings - Defense World

Jun 14, 2025
pulisher
Jun 14, 2025

Millennium Management LLC Sells 6,649 Shares of Exagen Inc. (NASDAQ:XGN) - Defense World

Jun 14, 2025
pulisher
Jun 11, 2025

Exagen Inc. Holds 2025 Annual Stockholder Meeting - TipRanks

Jun 11, 2025
pulisher
Jun 05, 2025

Northern Trust Corp Has $75,000 Position in Exagen Inc. (NASDAQ:XGN) - Defense World

Jun 05, 2025
pulisher
Jun 04, 2025

XGN Set to Participate in Virtual Meeting on June 11 | XGN Stock News - GuruFocus

Jun 04, 2025
pulisher
May 31, 2025

Exagen Inc. (NASDAQ:XGN) Short Interest Update - Defense World

May 31, 2025
pulisher
May 30, 2025

Exagen stock soars to 52-week high, hits $7.2 amid robust gains By Investing.com - Investing.com South Africa

May 30, 2025
pulisher
May 29, 2025

Exagen stock soars to 52-week high, hits $7.2 amid robust gains - Investing.com Nigeria

May 29, 2025
pulisher
May 19, 2025

Research Analysts Issue Forecasts for Exagen FY2025 Earnings - Defense World

May 19, 2025
pulisher
May 18, 2025

Exagen Inc.'s (NASDAQ:XGN) Shares Bounce 34% But Its Business Still Trails The Industry - simplywall.st

May 18, 2025
pulisher
May 17, 2025

Cantor Fitzgerald Issues Pessimistic Forecast for Exagen (NASDAQ:XGN) Stock Price - Defense World

May 17, 2025
pulisher
May 16, 2025

Cantor Fitzgerald Reaffirms Their Buy Rating on Exagen (XGN) - The Globe and Mail

May 16, 2025
pulisher
May 15, 2025

Exagen (XGN) Target Price Adjusted by Cantor Fitzgerald Followin - GuruFocus

May 15, 2025
pulisher
May 15, 2025

Exagen (XGN) Price Target Lowered by Cantor Fitzgerald, Rating Maintained | XGN Stock News - GuruFocus

May 15, 2025
pulisher
May 15, 2025

Cantor Fitzgerald cuts Exagen stock target to $7, maintains Overweight By Investing.com - Investing.com Canada

May 15, 2025
pulisher
May 15, 2025

Cantor Fitzgerald cuts Exagen stock target to $7, maintains Overweight - Investing.com

May 15, 2025
pulisher
May 15, 2025

Canaccord Genuity Group Forecasts Strong Price Appreciation for Exagen (NASDAQ:XGN) Stock - Defense World

May 15, 2025
pulisher
May 13, 2025

Exagen (XGN) Maintains 'Buy' Rating as Price Target Rises | XGN Stock News - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Exagen (XGN) Receives Increased Price Target from Canaccord | XG - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Exagen (XGN) Receives Increased Price Target from Canaccord | XGN Stock News - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Exagen prices public offering of common stock - MSN

May 13, 2025
pulisher
May 11, 2025

Exagen Inc. (NASDAQ:XGN) Q1 2025 Earnings Call Transcript - Insider Monkey

May 11, 2025
pulisher
May 10, 2025

Exagen Inc. Announces Closing of $20.2 Million Public Offering I - GuruFocus

May 10, 2025
pulisher
May 10, 2025

Exagen Inc. Announces Closing of $20.2 Million Public - GlobeNewswire

May 10, 2025
pulisher
May 10, 2025

Exagen Inc. anticipates $65M revenue for 2025 amid ASP growth and new biomarker launches - MSN

May 10, 2025
pulisher
May 09, 2025

Exagen Inc. Announces Closing of $20.2 Million Public Offering Including Full Exercise of Underwriter's Option to Purchase Additional Shares | XGN Stock News - GuruFocus

May 09, 2025
pulisher
May 09, 2025

Exagen Inc. Completes Additional Public Offering of 502,500 Shares, Raising Approximately $20.2 Million - Nasdaq

May 09, 2025
pulisher
May 09, 2025

Exagen Inc. Announces Closing of $20.2 Million Public Offering Including Full Exercise of ... - Bluefield Daily Telegraph

May 09, 2025
pulisher
May 09, 2025

Exagen Inc. Announces Closing of $20.2 Million Public Offering Including Full Exercise of Underwriter’s Option to Purchase Additional Shares - Stock Titan

May 09, 2025
pulisher
May 09, 2025

Earnings Update: Here's Why Analysts Just Lifted Their Exagen Inc. (NASDAQ:XGN) Price Target To US$7.75 - simplywall.st

May 09, 2025
pulisher
May 09, 2025

Exagen Inc (XGN)’s Ratio Roundup: Key Metrics for Trailing Twelve Months - DWinneX

May 09, 2025

Exagen Inc (XGN) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
diagnostics_research WAT
$296.92
price up icon 2.54%
diagnostics_research DGX
$168.18
price up icon 0.69%
$143.38
price down icon 3.38%
diagnostics_research LH
$247.24
price up icon 0.51%
diagnostics_research MTD
$1,205.68
price up icon 1.81%
diagnostics_research IQV
$163.25
price up icon 2.91%
자본화:     |  볼륨(24시간):